-
Utilization of Skin Punch Biopsy for the Diagnosis of Alpha-synucleinopathy in Clinical Practice
-
Utilizing a global network to study environmental factors relating to Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2)
-
Utilizing a tablet-based digital drawing to discriminate Parkinson’s disease from essential tremor
-
V-ATPase subunit V1G1 overexpression conferred the mice neuroprotection during MPTP exposure
-
Validating the clinical stage NLRP3 inflammasome inhibitor nibrozetone as a disease-modifying therapeutic for Parkinson’s disease
-
Validation of a New Patient-reported Outcome Scale for the Assessment of Essential Tremor
-
Validation of Inertial Measurement Units and an application compared with the reference system to assess the gait in hereditary spastic paraplegia
-
Validation of Inertial Monitoring Units for Gait Assessment in Progressive Supranuclear Palsy
-
Validation of PD Ascertainment in the VA Electronic Medical Record (EMR)
-
Validation of the International Parkinson and Movement Disorder Society – Non-Motor Symptoms – Questionnaire (MDS-NMS-Q)
- « Previous Page
- 1
- …
- 174
- 175
- 176
- 177
- 178
- …
- 181
- Next Page »